Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Lacosamide recalled?

Yes — there is an active recall. 6 ongoing FDA recalls mention Lacosamide (9 total). Check the affected lots below.

Most common reason: cGMP deviation (4 of these recalls)

Recalls are matched by product description. A recall usually affects specific lots, not every package of Lacosamide. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Lacosamide recalls in 2026

1 initiated in 2026, 9 in total — newest first
Class II · Moderate risk

Lacosamide Tablets

Presence of a Foreign Tablets: Complaint received, possible mix-up of Selexipag 1000 mcg tablet in a bottle of Lacosamide Tablets USP, 100mg.

Ongoing Particulate / foreign matter Annora Pharma Private Limited NDC 31722-813-60 D-0626-2026
Class II · Moderate risk

Lacosamide Oral Solution

Defective Container: This recall is being initiated due to a leaking unit stored horizontally.

Ongoing Packaging defect Apotex Corp. NDC 60505-0405-4 D-0457-2025
Class II · Moderate risk

Lacosamide Tablets

CGMP Deviations

Ongoing cGMP deviation Glenmark Pharmaceuticals Inc., USA NDC 68462-678-60 D-0337-2025
Class II · Moderate risk

Lacosamide Tablets

CGMP Deviations

Ongoing cGMP deviation Glenmark Pharmaceuticals Inc., USA NDC 68462-679-60 D-0330-2025
Class III · Low risk

Lacosamide Oral Solution

Failed Excipient Specifications: out of specification result observed for p-Hydroxybenzoic Acid content

Terminated Failed specification Camber Pharmaceuticals, Inc NDC 31722-627-26 D-0094-2023
Class II · Moderate risk

VIMPAT (lacosamide)

CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Terminated Temperature excursion Cardinal Health Inc. NDC 0131-2480-35 D-0590-2021
Class II · Moderate risk

VIMPAT (lacosamide)

CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Terminated Temperature excursion Cardinal Health Inc. D-0589-2021